絞り込み

16643

広告

Pharmacokinetics of Ginkgolide B Injection in Beagle Dogs.

著者 Song H , Bu F , Wei C , Yuan G , Liu X , Wang B , Guo R
Arzneimittelforschung.2012 Oct 23 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Institute of Clinical Pharmacology, Qilu Hospital of Shandong University, P.R. of China.

スターを付ける スターを付ける     (709view , 0users)

Full Text Sources

Miscellaneous

A liquid chromatography-mass spectrometry method was developed, validated, and applied to the pharmacokinetic study with doses of 0.68, 2.73 and 10.92 mg/kg of ginkgolide B in beagle dogs after intravenous infusion.An aliquot of blood samples were -collected, separated and quantitatively analyzed by liquid chromatography-mass spectrometry method with mobile phase of acetonitrile-0.02% ammonia solution (33:67, v/v) at a flow rate of 0.8 mL/min on the UltimateTM XB-C18 column (5 μm, 4.6×150 mm).The method was sensitive, accurate and convenient, and can be used for the determination of ginkgolide B in beagle dogs. The Cmax and AUC0-∞ of GB increased with dose escalation, but ANOVA analyses showed that no significant difference was observed in other pharmacokinetic parameters between different doses.An LC/MS method was developed with good sensitivity, reproducibility and specificity. In the pharmacokinetic study of GB in beagle dogs, linear pharmacokinetics was found at doses from 0.62 to 10.92 mg/kg after a single-dose intravenous infusion. Gender differences were not observed in the pharmacokinetics of GB.
PMID: 23093483 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード